Abatacept to Treat Steroid Refractory Chronic Graft Versus Host Disease (cGVHD)

NCT01954979 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

56

Enrollment

OTHER

Sponsor class

Conditions

Chronic Graft Versus Host Disease

Interventions

DRUG: Abatacept

Sponsor

Beth Israel Deaconess Medical Center

Collaborators

[object Object]
[object Object]